Therapeutic Approach to Hormone-Refractory Prostate Cancer

Oncology & Hematology Review (US)
doi 10.17925/ohr.2007.00.01.38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Hormone-Refractory Prostate Cancer

English

CS4 Bone Lesions in Hormone Refractory Prostate Cancer (HRPC)

Japanese Journal of Urology
Urology
2006English

Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2005English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Molecular Characterization of the Gγ-globin-Tag Transgenic Mouse Model of Hormone Refractory Prostate Cancer: Comparison to Human Prostate Cancer

Prostate
OncologyUrology
2010English

Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer

Japanese Journal of Urology
Urology
2011English

Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Letter

Clinical Cancer Research
Cancer ResearchOncology
2014English

Palliative Radiotherapy for Local Progression of Hormone Refractory Stage D2 Prostate Cancer

Japanese Journal of Urology
Urology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy